Prostate-Specific Antigen Kinetics Following 5α-Reductase Inhibitor Treatment May Be a Useful Indicator for Repeat Prostate Biopsy.
Ji Eun HeoKyo Chul KooSung Joon HongSang Un ParkByung Ha ChungKwang-Suk LeePublished in: Yonsei medical journal (2018)
The effects of 5ARIs on prostate cancer detection and chemoprevention remain uncertain. However, more than two increases in PSA level after 6 months of 5ARI treatment may indicate the presence of prostate cancer.